Strs Ohio Tricida, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$21.21 - $31.55 $110,292 - $164,060	-5,200 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$31.16 - $39.46 $12,464 - $15,784	400 Added 8.33%	5,200 $205,000
Q1 2019 Apr 19, 2019	BUY	$19.96 - $38.62 $29,940 - $57,929	1,500 Added 45.45%	4,800 $185,000
Q3 2018 Oct 19, 2018	BUY	$22.5 - $39.35 $74,250 - $129,855	3,300 New	3,300 $100,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.